you are here: HomeNewsCovishield
covishield
Jump to
194 Results Found
  • COVID-19 vaccine: Several European nations to resume use of AstraZeneca shots Mar 19, 2021 09:21 AM IST

    COVID-19 vaccine: Several European nations to resume use of AstraZeneca shots

    Germany, France, Italy and other European nations have announced plans to resume using AstraZeneca's COVID-19 vaccine.

  • COVID-19 vaccine: India to follow gap of 4-6 weeks even as WHO recommends 8-12 weeks Mar 18, 2021 10:00 AM IST

    COVID-19 vaccine: India to follow gap of 4-6 weeks even as WHO recommends 8-12 weeks

    The World Health Organization’s (WHO) has recommended a gap of 8-12 weeks between two doses of the AstraZeneca vaccine for better efficacy.

  • Coronavirus News Highlights: India backs AstraZeneca COVID-19 vaccine, will continue to use it in immunisation program Mar 17, 2021 07:47 AM IST

    Coronavirus News Highlights: India backs AstraZeneca COVID-19 vaccine, will continue to use it in immunisation program

    Coronavirus News Highlights: The cumulative number of COVID-19 vaccine doses administered in the country has crossed 3.48 crore, the Union health ministry said.

  • Govt places new purchase order with SII for 10 crore doses of Covishield vaccine Mar 16, 2021 08:09 PM IST

    Govt places new purchase order with SII for 10 crore doses of Covishield vaccine

    The cost of the 10 crore doses would be borne by the health ministry under the budgetary allocation for the purpose.

  • What India plans to do with Covishield, the AstraZeneca COVID-19 vaccine suspended by several countries? Mar 16, 2021 01:02 PM IST

    What India plans to do with Covishield, the AstraZeneca COVID-19 vaccine suspended by several countries?

    The World Health Organization has insisted the AstraZeneca shot is safe, and that there is no link between the vaccine and reported blood clots.

  • COVID-19 update | Chhattisgarh govt plans to allow use of Covaxin in state: Minister Mar 14, 2021 06:01 PM IST

    COVID-19 update | Chhattisgarh govt plans to allow use of Covaxin in state: Minister

    In January, Singh Deo had requested Union Health Minister Dr Harsh Vardhan to halt the supply of Covaxin, developed by Bharat Biotech, to the state until its phase-3 trials are completed and results are made available.

  • COVID-19 Update | Amid concerns over Covishield, India studies post-vaccination adverse events Mar 13, 2021 09:52 PM IST

    COVID-19 Update | Amid concerns over Covishield, India studies post-vaccination adverse events

    India has reported 234 adverse events following immunisation (AEFIs), including 71 deaths, for both the vaccines till Friday

  • COVID-19 update | 'No evidence' of higher blood clots risk from vaccine: AstraZeneca Mar 12, 2021 08:43 PM IST

    COVID-19 update | 'No evidence' of higher blood clots risk from vaccine: AstraZeneca

    Earlier, WHO said there was no reason to stop using AstraZeneca's COVID-19 vaccine after several European countries suspended the roll-out over blood clot fears.

  • AstraZeneca vaccine: Covishield suspended in 10 European countries over reports of blood clot Mar 12, 2021 09:20 AM IST

    AstraZeneca vaccine: Covishield suspended in 10 European countries over reports of blood clot

    Denmark, the first to announce it was suspending the jab, said that the move was precautionary.

  • COVID-19 vaccination | Price of Covishield renegotiated, to cost less than Rs 200 per dose, says Health Ministry Mar 11, 2021 09:42 PM IST

    COVID-19 vaccination | Price of Covishield renegotiated, to cost less than Rs 200 per dose, says Health Ministry

    So far, the government has allowed private health facilities to charge up to Rs 250 for one dose of the vaccine.

  • Coronavirus News Highlights | Maharashtra reports 13,659 new cases in the last 24 hours Mar 10, 2021 07:29 AM IST

    Coronavirus News Highlights | Maharashtra reports 13,659 new cases in the last 24 hours

    Coronavirus News Highlights : The cumulative number of COVID-19 vaccine doses administered in India has crossed 2.40 crore, according to the Union Health Ministry.

  • Coronavirus News Highlights| Janta Curfew to be imposed in Maharashtra's Jalgaon from 11 March till 15 March Mar 09, 2021 07:35 AM IST

    Coronavirus News Highlights| Janta Curfew to be imposed in Maharashtra's Jalgaon from 11 March till 15 March

    Coronavirus News Highlights: The cumulative number of COVID-19 vaccine doses administered in India has crossed 2.26 crore, according to the Union Health Ministry.

  • Efficacy data for India's own COVID-19 vaccine could boost public acceptance Mar 04, 2021 02:22 PM IST

    Efficacy data for India's own COVID-19 vaccine could boost public acceptance

    Government data shows dashboard.cowin.gov.in that only 10 percent of about 12.6 million people immunised in India have taken the COVAXIN shot, which was found to be 81 percent effective in an interim analysis of the late-stage trial, its developer Bharat Biotech said on Wednesday.

  • Delhi CM Arvind Kejriwal receives first dose of COVID-19 vaccine at LNJP hospital Mar 04, 2021 12:24 PM IST

    Delhi CM Arvind Kejriwal receives first dose of COVID-19 vaccine at LNJP hospital

    The Covishield vaccine was first administered to Kejriwal’s parents, Govind Ram Kejriwal and Gita Devi, and then to the chief minister.

  • EXPLAINED | Covaxin shows 81% efficacy, here's how it stacks up against Covishield Mar 03, 2021 08:43 PM IST

    EXPLAINED | Covaxin shows 81% efficacy, here's how it stacks up against Covishield

    Here is a comparison between the two COVID-19 vaccines – Covishield and Covaxin - approved in India.

  • COVID-19 vaccination drive | Should you get the jab? Check these side effects first Mar 03, 2021 11:46 AM IST

    COVID-19 vaccination drive | Should you get the jab? Check these side effects first

    COVID-19 vaccination drive was expanded on March 1 to include senior citizens and those aged 45-59 who have comorbidities.

  • Asaduddin Owaisi raises questions over Covishield as PM Modi receives Covaxin shot, asks govt to clear confusion Mar 01, 2021 08:20 PM IST

    Asaduddin Owaisi raises questions over Covishield as PM Modi receives Covaxin shot, asks govt to clear confusion

    In early January, India’s drug regulator had approved two vaccines — Bharat Biotech’s Covaxin and the Oxford/AstraZeneca-developed Covishield, which is being manufactured by Serum Institute of India (SII) — for emergency use in the country.

  • Covishield vs Covaxin: A comparison of COVID-19 vaccines administering in India Mar 01, 2021 10:28 AM IST

    Covishield vs Covaxin: A comparison of COVID-19 vaccines administering in India

    India has approved two vaccines—Covaxin developed by Hyderabad-based Bharat Biotech and Covishield from the Oxford-AstraZeneca stable being manufactured by the Serum Institute of India —for emergency use in the country.

  • COVID-19 | India's vaccine diplomacy helping other countries overcome pandemic challenge, received global praise Feb 17, 2021 01:35 PM IST

    COVID-19 | India's vaccine diplomacy helping other countries overcome pandemic challenge, received global praise

    Apart from Bharat Biotech’s Covaxin, Pune-based Serum Institute of India (SII) had collaborated with AstraZeneca and the University of Oxford and developed Covishield. This vaccine has been granted emergency approval in India. Let’s take a look at India’s vaccine diplomacy in various countries.

  • COVID-19 Vaccine Tracker | Over 85 lakh inoculated in India; Punjab, Tamil Nadu report less than 40% coverage Feb 16, 2021 08:52 AM IST

    COVID-19 Vaccine Tracker | Over 85 lakh inoculated in India; Punjab, Tamil Nadu report less than 40% coverage

    The second dose of COVID-19 vaccine is being given to those who received the first shot 28 days ago.

  • UK auditing Serum Institute's site amid scramble for shots Feb 15, 2021 08:35 PM IST

    UK auditing Serum Institute's site amid scramble for shots

    The inspection comes as countries around the world scramble to secure vaccine supplies amid supply disruptions and delivery cuts from leading drugmakers such as Pfizer Inc, Moderna and AstraZeneca.

  • COVID-19 vaccine tracker| India may emerge as second largest vaccine maker after the US: Report Feb 15, 2021 06:44 PM IST

    COVID-19 vaccine tracker| India may emerge as second largest vaccine maker after the US: Report

    Prior to COVID-19 pandemic, India had been producing 60 percent of the world's vaccines for various diseases at an affordable rate.

  • Will send Covishield to Canada in less than a month, says SII's Adar Poonawalla Feb 15, 2021 04:01 PM IST

    Will send Covishield to Canada in less than a month, says SII's Adar Poonawalla

    Covishield is the brand name for the AstraZeneca-Oxford University COVID-19 vaccine. Prime Minister Narendra Modi on February 10 had assured his Canadian counterpart Justin Trudeau that India would do its best to facilitate supplies of COVID vaccines sought by Canada.

  • Exclusive interview | Magma Fincorp is a full package; we welcome regulations that will help NBFCs stay disciplined: Adar Poonawalla Feb 11, 2021 03:02 PM IST

    Exclusive interview | Magma Fincorp is a full package; we welcome regulations that will help NBFCs stay disciplined: Adar Poonawalla

    Adar Poonawalla of Serum Institute of India speaks about his group’s NBFC interest, the rationale of the Magma Fincorp acquisition, RBI’s discussion paper for the segment and much more.

  • COVID-19 Vaccine Tracker | Over 56 lakh people get jabs; Uttar Pradesh leads with 6.73 lakh beneficiaries Feb 07, 2021 11:07 AM IST

    COVID-19 Vaccine Tracker | Over 56 lakh people get jabs; Uttar Pradesh leads with 6.73 lakh beneficiaries

    The highest number of people were vaccinated in Uttar Pradesh at 673,542 followed by Maharashtra at 463,044.

Sections